title: Vermont responds to its opioid crisis.
abstract: Vermont is one of the more forward-thinking states in the nation with a history of taking groundbreaking approaches to complex social issues. In his Jan 8, 2014 State of the State Address, Vermont Governor Peter Shumlin announced that Vermont was in the midst of an opioid addiction epidemic. Though Vermont had called attention to its opioid crisis, it soon became clear that many other states shared this problem. Economic modeling of expanded access to maintenance therapy with either methadone or buprenorphine is felt to have "high value" because the added health care costs of treatment are offset by reductions in other health care costs that occur when individuals with opioid dependence begin treatment. Moreover, when broader societal costs such as criminal activity and work productivity are included, maintenance treatment is estimated to produce substantial overall savings. Coordinated efforts between the Vermont Department of Health's Division of Alcohol and Drug Abuse Programs (ADAP) and the Department of Vermont Health Access (DVHA-Vermont Medicaid Authority) have resulted in the creation of the Care Alliance for Opioid Addiction (or Hub & Spoke model). Vermont intends to develop a reproducible and exportable model based on cost effective, outcomes driven public policy.
authors: Department of Vermont Health Access (Vermont Medicaid Authority), United States; Division for Integrated Health & Human Services UVM Center for Clinical & Translational Science, United States; Division of Public Psychiatry, University of Vermont College of Medicine & UVM Medical Center, United States. Electronic address: Thomas.Simpatico@uvm.edu.
authors: Thomas A
authors: TA
authors: Simpatico
mesh_terms: D002047:Buprenorphine / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D006291:Health Policy; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009294:Narcotics / Q000191:economics / Q000627:therapeutic use; D058850:Opiate Substitution Treatment / Q000191:economics*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000191:economics; D014707:Vermont
chemical_list: D009294:Narcotics; D002047:Buprenorphine; D008691:Methadone
keywords: Opioid substitution treatment; Public health; Public policy